直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Teva Pharmaceuticals International GmbH

Eli Lilly and Company

Represented Eli Lilly in patent litigations involving antibody therapies.

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, 1:18-cv-12029, D. Mass., Judge Burroughs

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Danielle A. Duszczyszyn, Ph.D.
Partner
Washington, DC
+1 202 408 4142
Email
Charles T. Collins-Chase
Partner
Washington, DC
+1 202 408 4108
Email
Daniel F. Roland
Partner
Washington, DC
+1 202 408 4318
Email
Sydney R. Kestle
Partner
Washington, DC
+1 202 408 4241
Email
Matthew J. Luneack
Partner
Washington, DC
+1 202 408 4436
Email
Emily R. Gabranski
Partner
Washington, DC
+1 202 408 4331
Email
Yoonjin Lee, Ph.D.
Partner
Washington, DC
+1 202 408 4332
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Biologics

Related Experiences

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals International

Eli Lilly and Company

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

Biogen International GmbH

Grünenthal GmbH v. Teva Pharmaceuticals

Grünenthal GmbH

When the patent for Zyprexa® and $2 billion in annual revenue were on the line, Eli Lilly turned to Finnegan

Eli Lilly and Company

Eli Lilly and Company v. Genentech, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Actavis Labs. UT Inc.

Eli Lilly and Company

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP